Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Saunders-Pullman

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|April 4, 2017
The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging StudiesClaustre Pont-Sunyer, Eduardo Tolosa, Chelsea Caspell-Garcia, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 4, 2020
Seizure-related 6 homolog like 2 autoimmunity: Neurologic syndrome and antibody effectsJon Landa, Mar Guasp, Mar Petit-Pedrol, et al.
American Journal of Medical Genetics. Part A|August 21, 2007
Narrowing the DYT6 dystonia region and evidence for locus heterogeneity in the Amish-MennonitesRachel Saunders-Pullman, Deborah Raymond, Geetha Senthil, et al.
JAMA Network Open|April 21, 2021
Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease ProgressionRoberto A Ortega, Cuiling Wang, Deborah Raymond, et al.
JAMA Neurology|May 31, 2017
Complex and Dynamic Chromosomal Rearrangements in a Family With Seemingly Non-Mendelian Inheritance of Dopa-Responsive DystoniaKatja Lohmann, Claire Redin, Holger Tönnies, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 27, 2015
Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 geneAnat Mirelman, Roy N Alcalay, Rachel Saunders-Pullman, et al.
JAMA Neurology|January 9, 2018
Progression in the LRRK2-Asssociated Parkinson Disease PopulationRachel Saunders-Pullman, Anat Mirelman, Roy N Alcalay, et al.
NPJ Parkinson'S Disease|December 7, 2023
Genetic risk variants in New Yorkers of Puerto Rican and Dominican Republic heritage with Parkinson's diseaseGabriel Miltenberger-Miltenyi, Roberto A Ortega, Aloysius Domingo, et al.
Annals of Clinical and Translational Neurology|January 20, 2016
Psychiatric disorders, myoclonus dystonia and SGCE: an international studyKathryn J Peall, Joke M Dijk, Rachel Saunders-Pullman, et al.
Neurology|March 29, 2013
The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson diseaseZiv Gan-Or, Laurie J Ozelius, Anat Bar-Shira, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Movement Disorders : Official Journal of the Movement Disorder Society|April 4, 2017
The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging StudiesClaustre Pont-Sunyer, Eduardo Tolosa, Chelsea Caspell-Garcia, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 4, 2020
Seizure-related 6 homolog like 2 autoimmunity: Neurologic syndrome and antibody effectsJon Landa, Mar Guasp, Mar Petit-Pedrol, et al.
American Journal of Medical Genetics. Part A|August 21, 2007
Narrowing the DYT6 dystonia region and evidence for locus heterogeneity in the Amish-MennonitesRachel Saunders-Pullman, Deborah Raymond, Geetha Senthil, et al.
JAMA Network Open|April 21, 2021
Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease ProgressionRoberto A Ortega, Cuiling Wang, Deborah Raymond, et al.
JAMA Neurology|May 31, 2017
Complex and Dynamic Chromosomal Rearrangements in a Family With Seemingly Non-Mendelian Inheritance of Dopa-Responsive DystoniaKatja Lohmann, Claire Redin, Holger Tönnies, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 27, 2015
Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 geneAnat Mirelman, Roy N Alcalay, Rachel Saunders-Pullman, et al.
JAMA Neurology|January 9, 2018
Progression in the LRRK2-Asssociated Parkinson Disease PopulationRachel Saunders-Pullman, Anat Mirelman, Roy N Alcalay, et al.
NPJ Parkinson'S Disease|December 7, 2023
Genetic risk variants in New Yorkers of Puerto Rican and Dominican Republic heritage with Parkinson's diseaseGabriel Miltenberger-Miltenyi, Roberto A Ortega, Aloysius Domingo, et al.
Annals of Clinical and Translational Neurology|January 20, 2016
Psychiatric disorders, myoclonus dystonia and SGCE: an international studyKathryn J Peall, Joke M Dijk, Rachel Saunders-Pullman, et al.
Neurology|March 29, 2013
The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson diseaseZiv Gan-Or, Laurie J Ozelius, Anat Bar-Shira, et al.
Pageof 14